CVS Health Corporation (FRA:CVS)
Germany
· Delayed Price · Currency is EUR | Market Cap | 73.73B |
| Revenue (ttm) | 348.56B |
| Net Income (ttm) | 4.89B |
| Shares Out | n/a |
| EPS (ttm) | 3.88 |
| PE Ratio | 15.09 |
| Forward PE | 10.40 |
| Dividend | 2.44 (4.15%) |
| Ex-Dividend Date | Apr 22, 2025 |
| Volume | 318 |
| Average Volume | 344 |
| Open | 58.12 |
| Previous Close | 58.50 |
| Day's Range | 55.59 - 58.12 |
| 52-Week Range | 41.94 - 64.13 |
| Beta | n/a |
| RSI | 38.54 |
| Earnings Date | May 1, 2025 |
About CVS Health
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, coll... [Read more]
Financial Performance
In 2024, CVS Health's revenue was $370.66 billion, an increase of 3.93% compared to the previous year's $356.62 billion. Earnings were $4.61 billion, a decrease of -44.70%.
Financial numbers in USD Financial StatementsNews
Cigna and CVS shares fall as Trump targets ‘middlemen' in sweeping executive order against Big Pharma
The market reaction came as Trump signed a wide-ranging executive order aimed at slashing prescription drug prices in the US.
Trump's drug pricing order delivers blow to pharmacy benefit managers
President Donald Trump on Monday delivered a blow to the private-sector middlemen who negotiate U.S. drug prices in his executive order on drug pricing, saying he would cut them out as part of a goal ...
President Trump's EO to lower drug prices is the beginning of a long process, says Jeff Jonas
Jeff Jonas, Gabelli Funds portfolio manager, joins CNBC's 'Power Lunch' to discuss reactions to President Trump's executive order to lower drug prices, the impact to pharma companies, and more.
CVS Health celebrates reopening of Hendersonville store destroyed by Hurricane Helene
The South Main Street CVS Pharmacy is again providing health, wellness and pharmacy services to customers and patients WOONSOCKET, R.I. , May 12, 2025 /PRNewswire/ -- Today, leaders from CVS Health® (...
Cigna, CVS down as Trump targets 'drug middlemen' in drug prices EO
Levi & Korsinsky Investigates Possible Securities Fraud Violations by CVS Health Corporation (CVS)
NEW YORK, NY / ACCESS Newswire / May 12, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of CVS Health Corporation ("CVS Health Corporation") (NYSE:CVS) concerning po...
CVS Health: Big 2025 Momentum, Strong Growth Ahead, Shares Underpriced
CVS Health: Firing On All Cylinders, Thanks To The Promising Reversal
3 Ideal Buys From 63 May Fortune 500 Industry Leaders
The June/July 2024 Fortune Magazine revealed 500 biggest U.S. companies by-revenue and profits. Arnold-research focused on those industry-leaders using YCharts 5/7/25 data of Profits from 63. 63 Fortu...
AM Best Affirms Credit Ratings of CVS Health Corporation’s Aetna Inc. Subsidiaries
AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of “a” (Excellent) of Aetna Life Insurance Company (ALIC) (Hartford, ...
ATTENTION CVS SHAREHOLDERS: Investors Who Lost Money on CVS Health Corporation Are Urged to Contact Levi & Korsinsky About an Ongoing Investigation
NEW YORK, NY / ACCESS Newswire / May 8, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of CVS Health Corporation ("CVS Health Corporation") (NYSE:CVS) concerning pos...
CVS Backs Health-Tech Firm Kouper's $10 Million Fundraise
Health technology platform Kouper has emerged from stealth after raising $10 million. The company announced the new financing — from investors including General Catalyst, 25Madison and CVS Health Vent...
CVS Health’s Q1 beat prompts Glenview Capital to lower stake
Healthy Returns: Novo Nordisks Wegovy deal with CVS won't derail Eli Lilly's obesity market dominance
Eli Lilly won't lose its grip on the weight loss market despite recent investor concerns. Meanwhile, Zocdoc releases an AI-powered scheduling assistant.
Kirby McInerney LLP Announces Investigation of Claims Against CVS Health Corporation (CVS) on Behalf of Investors
NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against CVS Health Corporation (“CVS” or the “Company”) (NYSE:CVS). The investigation c...
Build A 12%+ Yield On Cost By 2035 With May's Top 10 High-Yield Picks
In this article, I present 10 attractive high-yield investment options for this month of May 2025, which not only offer dividend income but also potential for dividend growth. The selection process in...
Activist investor Glenview Capital reduces stake in CVS Health
Activist investor Glenview Capital said on Tuesday it reduced its holdings in CVS Health by 3.75 million shares after the insurer posted "healthy" first-quarter results and raised annual forecast.
Glenview Capital Issues Statement on CVS Health
NEW YORK , May 6, 2025 /PRNewswire/ -- One year ago, we established a concentrated position in shares of CVS Health (NYSE: CVS). Since our purchases in May 2024, CVS shares have generated a total retu...
Notable healthcare headlines for the week: Gilead, CVS Health, Sanofi in focus
Stay updated on top pharmaceutical news: Merck's $3.9B SpringWorks deal, Hims & Hers' Wegovy partnership, CVS exiting Obamacare, and FDA updates on key drugs.
CVS Health (CVS) Exceeds Earnings Expectations, Analysts Maintain Revenue Forecasts
CVS Health (CVS) Exceeds Earnings Expectations, Analysts Maintain Revenue Forecasts
CVS Health (CVS) Exceeds Q1 Expectations with Revenue and EPS Gains
CVS Health (CVS) Exceeds Q1 Expectations with Revenue and EPS Gains
Eli Lilly Stock Offers Buying Opportunity For Goldman Sachs. Concerns Over CVS Setback Are Overblown, Analysts Say
Eli Lilly and Co (NYSE: LLY) on Thursday reported first-quarter earnings and lowered its 2025 guidance . The U.S. pharma giant reported January-March revenue of $12.73 billion, up 45% year over year ...
Cigna CEO Says Strong Q1 Earnings, Increased Outlook Reflect Strength In Growth Platforms
Cigna Group (NYSE: CI) on Friday reported first-quarter 2025 revenue of $65.45 billion, beating analyst estimates of $60.39 billion . Sales increased 14% year over year, reflecting the growth of exis...
Decoding CVS Health Corp (CVS): A Strategic SWOT Insight
Decoding CVS Health Corp (CVS): A Strategic SWOT Insight
Breaking down 3 takeaways from healthcare earnings
Yahoo Finance Senior Health Reporter Anjalee Khemlani joins the Wealth team in breaking down the biggest themes she is seeing in the healthcare space from this earnings season, ranging from CVS Health...